This live web event has ended. Thank you for attending. 0 of 8 Sessions Available MAY 05 May 05, 2020 Tue 12:00 PM EDT 1H Closed Wanda Phipatanakul, MD, MS OCT 14 October 14, 2020 Wed 6:00 PM EDT 1H Closed OCT 22 October 22, 2020 Thu 12:30 PM PDT 1H Closed NOV 11 November 11, 2020 Wed 12:00 PM EST 1H Closed Leonard B. Bacharier, MD NOV 19 November 19, 2020 Thu 6:00 PM PST 1H Closed DEC 04 December 04, 2020 Fri 3:00 PM CST 1H Closed DEC 10 December 10, 2020 Thu 4:00 PM PST 1H Closed JAN 23 January 23, 2021 Sat 9:00 AM CST 1H Closed Contributors Leonard B. Bacharier, MD Robert C. Strunk Endowed Chair for Lung and Respiratory ResearchProfessor of Pediatrics and MedicineClinical Director, Division of Pediatric Allergy, Immunology, & Pulmonary MedicineUnit Co-Leader, Patient Oriented Research UnitSt. Louis, MOLeonard B. Bacharier, MD is the Robert C. Strunk Endowed Chair for Lung and Respiratory Research, Professor of Pediatrics and Medicine, and Clinical Director of the Division of Pediatric Allergy, Immunology, and Pulmonary Medicine at Washington University School of Medicine in St Louis, MO. His research focuses on childhood asthma and he is an investigator for several National Institutes of Health (NIH)-funded asthma programs, including AsthmaNet, the Inner City Asthma Consortium, and PrecISE.Dr. Bacharier is currently investigating the role of early infection with respiratory syncytial virus upon the subsequent development of asthma. He serves as an Associate Editor for the Journal of Allergy and Clinical Immunology, as a member of the Global Initiative for Asthma (GINA) Science Committee, and as Chair of the American Board of Allergy and Immunology. Wanda Phipatanakul, MD, MS Professor of PediatricsHarvard Medical SchoolDirector, Asthma Clinical Research CenterBoston Children's HospitalBoston, MAWanda Phipatanakul, MD, MS is Director of the Asthma Clinical Research Center at Boston Children’s Hospital and Professor of Pediatrics at Harvard Medical School. She has dedicated her career to reducing and preventing asthma and allergic diseases.Originally from St. Louis, she earned her medical degree from Loma Linda University and completed her residency in pediatrics at Children’s Hospital Los Angeles in 1997. After a fellowship in immunology at Johns Hopkins University, she joined the faculty in the Division of Immunology and Allergy at Boston Children’s and Harvard Medical School, where she has remained for the past 19 years.Dr. Phipatanakul has built a deep network of community relationships and conducts both school- and home-based asthma studies in children. She has also had continuous National Institutes of Health (NIH) funding for nearly 20 years. She leads the National Institute of Allergy and Infectious Diseases (NIAID) School Inner-City Asthma Intervention Study and the National Heart, Lung, and Blood Institute (NHLBI) Environment Assessment of Sleep in Youth. She is the overall Principal Investigator for an NIAID-funded, nationwide, multicenter asthma-prevention study evaluating omalizumab (anti-IgE) in preventing the atopic march and asthma.Most recently, Dr. Phipatanakul was awarded an NIAID U01 evaluating whether patients carrying an IL4RαR576 gene variant will have a greater response to dupilumab. She leads her Center as Pediatric PI in multiple NHLBI asthma and prevention networks, including Precise, and has authored more than 220 publications in scientific journals, including JAMA and the New England Journal of Medicine. She is passionate about successfully mentoring the next generation of investigators, serving the American Academy of Allergy, Asthma & Immunology (AAAAI) and the American Board of Allergy and Immunology (ABAI) in support of her specialty, and serving as a role model to others balancing work and family.